Rapid calcium-dependent activation of Aurora-A kinase

Nature Communications

Volumn 1, Issue 6, 2010, Pages

  Plotnikova, Olga V ^a   Pugacheva, Elena N ^b   Dunbrack, Roland L ^a   Golemis, Erica A ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; CALCIUM ION; CALMODULIN; AURORA KINASE; CALCIUM; PROTEIN SERINE THREONINE KINASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME BINDING; HUMAN; HUMAN CELL; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; ANIMAL; CELL LINE; CELL STRAIN HEK293; CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PROTEIN BINDING; SEQUENCE HOMOLOGY; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CALCIUM; CALMODULIN; CELL LINE; ENDOPLASMIC RETICULUM; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 78650077660     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1061     Document Type: Article

References (60)

1. Marumoto, T., Zhang, D. & Saya, H. Aurora-A-a guardian of poles. Nat. Rev. Cancer 5, 42-50 (2005).
2. Fukuda, T., Mishina, Y., Walker, M.P. & DiAugustine, R.P. Conditional transgenic system for mouse aurora a kinase: degradation by the ubiquitin proteasome pathway controls the level of the transgenic protein. Mol. Cell. Biol. 25, 5270-5281 (2005). (Pubitemid 40781123)
3. Pugacheva, E.N. & Golemis, E.A. HEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networks. Cell Cycle 5, 384-391 (2006).
4. Hirota, T. et al. Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 1 14, 585-598 (2003). (Pubitemid 37159255)
5. Zhao, Z.S., Lim, J.P., Ng, Y.W., Lim, L. & Manser, E. The GIT-associated kinase PAK targets to the centrosome and regulates Aurora-A. Mol. Cell 2 0, 237-249 (2005). (Pubitemid 41484169)
6. Hutterer, A. et al. Mitotic activation of the kinase Aurora-A requires its binding partner Bora. Dev. Cell 1 1, 147-157 (2006). (Pubitemid 44138495)
7. Bayliss, R., Sardon, T., Vernos, I. & Conti, E. Structural basis of Aurora-A activation by TPX2 at the mitotic spindle. Mol. Cell 1 2, 851-862 (2003). (Pubitemid 37352779)
8. Satinover, D.L., Leach, C.A., Stukenberg, P.T. & Brautigan, D.L. Activation of Aurora-A kinase by protein phosphatase inhibitor-2, a bifunctional signaling protein. Proc. Natl Acad. Sci. USA 1 01, 8625-8630 (2004). (Pubitemid 38745821)
9. Pugacheva, E.N. & Golemis, E.A. The focal adhesion scaff olding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome. Nat. Cell. Biol. 7, 937-946 (2005). (Pubitemid 41486266)
10. Bischoff, J.R. et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 1 7, 3052-3065 (1998). (Pubitemid 28254378)
11. Zhou, H. et al. Tumour amplified kinase STK15/BTAKinduces centrosome amplification, aneuploidy and transformation. Nat. Genet. 2 0, 189-193 (1998). (Pubitemid 28455454)
12. Goepfert, T.M. et al. Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis. Cancer Res. 6 2, 4115-4122 (2002). (Pubitemid 34791083)
13. Tanner, M.M. et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin. Cancer Res. 6, 1833-1839 (2000). (Pubitemid 30305079)
14. Tanaka, T. et al. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res. 5 9, 2041-2044 (1999). (Pubitemid 29217660)
15. Meraldi, P., Honda, R. & Nigg, E.A. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/-cells. EMBO J. 2 1, 483-492 (2002). (Pubitemid 34174030)
16. Anand, S., Penrhyn-Lowe, S. & Venkitaraman, A.R. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 3, 51-62 (2003). (Pubitemid 37443890)
17. Zhang, D. et al. Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene 2 3, 8720-8730 (2004). (Pubitemid 39593287)
18. Tatsuka, M. et al. Multinuclearity and increased ploidy caused by overexpression of the aurora-and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res. 5 8, 4811-4816 (1998). (Pubitemid 28503674)
19. Andrews, P.D. Aurora kinases: shining lights on the therapeutic horizon? Oncogene 2 4, 5005-5015 (2005). (Pubitemid 41129079)
20. Wu, J.C. et al. Identification of V23RalA-Ser194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small pool expression screening.J. Biol. Chem. 2 80, 9013-9022 (2005).
21. Pugacheva, E.N., Jablonski, S.A., Hartman, T.R., Henske, E.P. & Golemis, E.A. HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell 1 29, 1351-1363 (2007). (Pubitemid 46962087)
22. Wong, S.Y. et al. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat. Med. 1 5, 1055-1061 (2009).
23. Lorenzo, C., Liao, Q., Hardwicke, M.A. & Ducommun, B. Pharmacological inhibition of aurora-A but not aurora-B impairs interphase microtubule dynamics. Cell Cycle 8, 1733-1737 (2009).
24. Kurahashi, T., Miyake, H., Hara, I. & Fujisawa, M. Significance of Aurora-A expression in renal cell carcinoma. U rol. Oncol. 2 5, 128-133 (2007). (Pubitemid 46349746)
25. Pan, J., Wang, Q. & Snell, W.J. An aurora kinase is essential for flagellar disassembly in Chlamydomonas. Dev. Cell 6, 445-451 (2004). (Pubitemid 38364575)
26. Huang, K. et al. Function and dynamics of PKD2 in Chlamydomonas reinhardtii flagella.J. Cell Biol. 179, 501-514 (2007). (Pubitemid 350074793)
27. Wheeler, G.L., Joint, I. & Brownlee, C. Rapid spatiotemporal patterning of cytosolic Ca2+ underlies flagellar excision in Chlamydomonas reinhardtii. Plant J. 5 3, 401-413 (2008). (Pubitemid 351172014)
28. Sun, L. et al. Ca2+ homeostasis regulates Xenopus oocyte maturation. Biol. Reprod. 7 8, 726-735 (2008). (Pubitemid 351469340)
29. Cai, Y. et al. Calcium dependence of polycystin-2 channel activity is modulated by phosphorylation at Ser812.J. Biol. Chem. 279, 19987-19995 (2004). (Pubitemid 38623441)
30. Koulen, P. et al. Polycystin-2 is an intracellular calcium release channel. Nat. Cell Biol. 4, 191-197 (2002). (Pubitemid 34218192)
31. Thibonnier, M., Bayer, A.L., Simonson, M.S. & Kester, M. Multiple signaling pathways of V1-vascular vasopressin receptors of A7r5 cells. Endocrinology 129, 2845-2856 (1991).
32. Sagara, Y. & Inesi, G. Inhibition of the sarcoplasmic reticulum Ca2+ transport ATPase by thapsigargin at subnanomolar concentrations. J. Biol. Chem. 266, 13503-13506 (1991). (Pubitemid 21907377)
33. Anyatonwu, G.I., Estrada, M., Tian, X., Somlo, S. & Ehrlich, B.E. Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2. Proc. Natl Acad. Sci. USA 1 04, 6454-6459 (2007). (Pubitemid 47186115)
34. Soncini, C. et al. PHA-680632 a novel Aurora kinase inhibitor with potent antitumoral activity. Clin. Cancer Res. 1 2, 4080-4089 (2006). (Pubitemid 44078096)
35. Zhang, Z., Hernandez-Lagunas, L., Horne, W.C. & Baron, R. Cytoskeletondependent tyrosine phosphorylation of the p130(Cas) family member HEF1 downstream of the G protein-coupled calcitonin receptor. Calcitonin induces the association of HEF1, paxillin, and focal adhesion kinase.J. Biol. Chem. 2 74, 25093-25098 (1999).
36. Zhang, Z., Neff, L., Bothwell, A.L., Baron, R. & Horne, W.C. Calcitonin induces dephosphorylation of Pyk2 and phosphorylation of focal adhesion kinase in osteoclasts. Bone 3 1, 359-365 (2002). (Pubitemid 35299614)
37. Fancelli, D. et al. 1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.J. Med. Chem. 4 9, 7247-7251 (2006). (Pubitemid 44886012)
38. Littlepage, L.E. et al. Identification of phosphorylated residues that affect the activity of the mitotic kinase Aurora-A. Proc. Natl Acad. Sci. USA 9 9, 15440-15445 (2002). (Pubitemid 35403953)
39. Littlepage, L.E. & Ruderman, J.V. Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit. Genes Dev. 1 6, 2274-2285 (2002). (Pubitemid 35013090)
40. Radivojac, P. et al. Calmodulin signaling: analysis and prediction of a disorderdependent molecular recognition. Proteins 63, 398-410 (2006).
41. Finn, R.D. et al. The Pfam protein families database. Nucleic Acids Res. 38, D211-D222.
42. McGuffin, L.J., Bryson, K. & Jones, D.T. The PSIPRED protein structure prediction server. Bioinformatics 1 6, 404-405 (2000). (Pubitemid 30417087)
43. Jones, D.T. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol. 2 92, 195-202 (1999). (Pubitemid 29435759)
44. Hofer, F., Berdeaux, R. & Martin, G.S. Ras-independent activation of Ral by a Ca(2+)-dependent pathway. Curr. Biol. 8, 839-842 (1998). (Pubitemid 28324540)
45. Clough, R.R., Sidhu, R.S. & Bhullar, R.P. Calmodulin binds RalA and RalB and is required for the thrombin-induced activation of Ral in human platelets. J. Biol. Chem. 2 77, 28972-28980 (2002).
46. Harris, P.C. & Torres, V.E. Polycystic kidney disease. Annu. Rev. Med. 60, 321-337 (2009).
47. Law, S.F. et al. Dimerization of the docking/adaptor protein HEF1 via a carboxy-terminal helix-loop-helix domain. Exp. Cell Res. 2 52, 224-235 (1999). (Pubitemid 29485141)
48. Li, X. et al. Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2. Nat. Cell Biol. 7, 1102-1112 (2005). (Pubitemid 41741732)
49. Parry, H., McDougall, A. & Whitaker, M. Microdomains bounded by endoplasmic reticulum segregate cell cycle calcium transients in syncytial Drosophila embryos. J. Cell Biol. 1 71, 47-59 (2005). (Pubitemid 41434601)
50. Roderick, H.L. & Cook, S.J. Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat. Rev. Cancer 8, 361-375 (2008). (Pubitemid 351589702)
51. O'Neill, G.M. & Golemis, E.A. Proteolysis of the docking protein HEF1 and implications for focal adhesion dynamics. Mol. Cell. Biol. 2 1, 5094-5108 (2001). (Pubitemid 32656406)
52. Law, S.F., Zhang, Y.-Z., Klein-Szanto, A. & Golemis, E.A. Cell-cycle regulated processing of HEF1 to multiple protein forms differentially targeted to multiple compartments. Mol. Cell. Biol. 18, 3540-3551 (1998). (Pubitemid 28240526)
53. Dosztanyi, Z., Csizmok, V., Tompa, P. & Simon, I. IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content. Bioinformatics 2 1, 3433-3434 (2005). (Pubitemid 41222453)
54. Ishida, T. & Kinoshita, K. Prediction of disordered regions in proteins based on the meta approach. Bioinformatics 24, 1344-1348 (2008). (Pubitemid 351737139)
55. Xue, B., Dunbrack, R.L., Williams, R.W., Dunker, A.K. & Uversky, V.N. PONDR-FIT: a meta-predictor of intrinsically disordered amino acids. Biochim. Biophys. Acta 1804, 996-1010 (2010).
56. Peng, K. et al. Optimizing long intrinsic disorder predictors with protein evolutionary information. J. Bioinform. Comput. Biol. 3, 35-60 (2005). (Pubitemid 40305483)
57. Altschul, S.F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 2 5, 3389-3402 (1997). (Pubitemid 27359211)
58. Apweiler, R et al. The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res. 38, D142-D148 (2009).
59. Larkin, M.A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948 (2007). (Pubitemid 350162903)
60. North, W.G., Fay, M.J. & Du, J. MCF-7 breast cancer cells express normal forms of all vasopressin receptors plus an abnormal V2R. Peptides 2 0, 8 37-8 42 (1 999). (Pubitemid 29378285)